Skip to main content

Table 1 Characteristics of patients with acute myeloid leukemia

From: Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells

Karyotype

abnormalities

Therapy

Cause of death

+ 8

DAC

Sepsis after induction therapy

Normal

DAC, consolidation, AlloHSCT

GvHD, infection complications

Unknown

DAC

Sepsis after induction therapy

Unknown

CLAG

Refractoriness on therapy

Inv(16)

DAC, consolidation

Alive

Complex changes

CLAG

Refractoriness on therapy

Normal

DAC, consolidation

Relapse

t(8;21)

DAC, consolidation

Alive

-Y

DAC, consolidation

Aspergillosis

Complex changes

DAC, CLAG-M, consolidation, AlloHSCT

Relapse

Normal

DAC, consolidation, AlloHSCT

Relapse

Complex changes

DAC, consolidation, AlloHSCT

Relapse

Normal

DAC, CLAG-M

Refractoriness on therapy, aspergillosis

Normal

DAC, Consolidation, AlloHSCT

Relapse